These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1718687)

  • 1. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I).
    Koltai M; Hosford D; Guinot P; Esanu A; Braquet P
    Drugs; 1991 Jul; 42(1):9-29. PubMed ID: 1718687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure.
    Lefer AM
    Crit Care Clin; 1989 Apr; 5(2):331-52. PubMed ID: 2650821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of PAF antagonists in experimental models. Therapeutical perspectives].
    Desquand S
    Therapie; 1993; 48(6):585-97. PubMed ID: 8091344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor antagonists.
    Saunders RN; Handley DA
    Annu Rev Pharmacol Toxicol; 1987; 27():237-55. PubMed ID: 3555317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H; Demos M; Wong A
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor--key mediator in neuroinjury?
    Frerichs KU; Feuerstein GZ
    Cerebrovasc Brain Metab Rev; 1990; 2(2):148-60. PubMed ID: 2201347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor in cardiovascular stress situations.
    Rabinovici R; Yue TL; Feuerstein G
    Lipids; 1991 Dec; 26(12):1257-63. PubMed ID: 1819713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor (PAF) and PAF antagonists in asthma.
    Hosford D; Mencia-Huerta JM; Braquet P
    Crit Rev Ther Drug Carrier Syst; 1990; 7(3):261-73. PubMed ID: 2073689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury.
    Loucks EB; Symersky P; Qayumi AK
    J Invest Surg; 1997; 10(6):321-38. PubMed ID: 9654389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Activating Factor antagonists.
    Afroz S; Ara A; Arif M
    Pak J Pharm Sci; 1998 Jul; 11(2):5-12. PubMed ID: 16414813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor and cytokine interactions in shock.
    Hosford D; Paubert-Braquet M; Braquet P
    Resuscitation; 1989 Dec; 18(2-3):207-18. PubMed ID: 2555874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor and shock.
    Feuerstein G; Siren AL
    Prog Biochem Pharmacol; 1988; 22():181-90. PubMed ID: 3043432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of platelet-activating factor (PAF) in experimental glomerular injury.
    Ortiz A; Gomez-Chiarri M; Lerma JL; Gonzalez E; Egido J
    Lipids; 1991 Dec; 26(12):1310-5. PubMed ID: 1819722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis.
    Kelefiotis D; Vakirtzi-Lemonias C
    Agents Actions; 1993 Nov; 40(3-4):150-6. PubMed ID: 8023738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF. A review of its effects, antagonists and possible future clinical implications (Part II).
    Koltai M; Hosford D; Guinot P; Esanu A; Braquet P
    Drugs; 1991 Aug; 42(2):174-204. PubMed ID: 1717219
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet activating factor and its role in trauma, shock, and sepsis.
    Ayala A; Chaudry IH
    New Horiz; 1996 May; 4(2):265-75. PubMed ID: 8774801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor antagonists.
    Negro Alvarez JM; Miralles López JC; Ortiz Martínez JL; Abellán Alemán A; Rubio del Barrio R
    Allergol Immunopathol (Madr); 1997; 25(5):249-58. PubMed ID: 9395010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activating factor (PAF) and its role in cardiac injury.
    Lefer AM
    Prog Clin Biol Res; 1989; 301():53-60. PubMed ID: 2678133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor (PAF)-antagonists of natural origin.
    Singh P; Singh IN; Mondal SC; Singh L; Garg VK
    Fitoterapia; 2013 Jan; 84():180-201. PubMed ID: 23160091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids.
    Mest HJ; Riedel A; Braquet P; Meyer E
    Biomed Biochim Acta; 1988; 47(10-11):S219-23. PubMed ID: 3248107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.